Project Grant DP2DK139544

Award Date 9/1/23
Completion Date 8/31/26
Dollars Obligated $1.4M
Funding Federal Agency
Office of the Director
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
North Carolina, USA
Similar Awards
The National Institutes of Health Office of the Director awarded the University of Southern California a $2.9 million project grant under the Trans-NIH Research Support program (CFDA 93.310) to develop a synthetic kidney as a revolutionary solution to the shortage of kidneys available for transplantation. The three-year project will generate a transplantable synthetic kidney using stem cell and bioengineering technologies, then evaluate its growth, differentiation, vascularization and functional...
This $700,619 federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to study and control rhythmic nephron formation for kidney replacement tissues. The primary awardee, The Trustees of the University of Pennsylvania, aims to define the spatiotemporal coordination of cell-cell interactions that drive the rhythmic...
This $117,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to use a systems biology approach to identify gene regulatory networks related to hypoxia inducible factor-1A (HIF1A) in the kidney cortex and medulla. The research project, led by the Regents of the University of Michigan, seeks to: 1) validate predicted transcription factor...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) awarded a $1,319,060 Project Grant to Duke University under the Trans-NIH Research Support (CFDA 93.310) program. The grant, effective September 1, 2023 through August 31, 2026, will fund research to study the robust formation of organs, with a focus on the development of the semicircular canals in the inner ear of zebrafish. The research aims to measure variations in tissue patterns, investigate the respective...
This federal Project Grant award for $689,095 was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research to understand the ecological causes of gut microbiome dysbiosis in chronic kidney disease (CKD) and determine if these microbiome changes have a causative effect on CKD progression. Specifically, the research aims to investigate how...
The University of Delaware was awarded a Project Grant of $238,184 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a part of the National Institutes of Health (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program), with a project period from Sep 6, 2024 to Aug 31, 2026. The grant funding will support the development of an "easy-to-use modular 3D model of the developing nephron" to investigate the critical structural and...
This Project Grant award, valued at $421,067.00, was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award will fund a research project at the University of North Carolina at Chapel Hill (UNC-CH) to investigate the effects of pregestational diabetes on the development of kidney organoids, a model system for studying human kidney development. The key objectives of the...
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $200,000 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to the University of North Carolina at Chapel Hill. The grant will fund research to study the effect of NRF2 activation on vascular smooth muscle cell phenotype and assess a new local therapeutic approach that activates NRF2 in a mouse arteriovenous fistula (AVF) stenosis model....
This federal Project Grant award for $200,000.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to improve the counseling and selection of living kidney donors. The grantee, New York University School of Medicine, will use this funding to conduct a case-cohort study to identify novel determinants of living kidney donor risk, including genetic, clinical,...
This $148,476 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to investigate methods for long-term, kidney-specific depletion of resident macrophages as a potential therapeutic approach for autosomal dominant polycystic kidney disease (ADPKD). The research aims to map the kinetics and mechanism of kidney resident macrophage...

The Department of Health and Human Services National Institutes of Health (NIH) awarded Duke University a $1,425,761 Project Grant under the Trans-NIH Research Support (CFDA 93.310) federal grant program. The purpose of this 3-year award is to harness stem cells and synthetic gene circuits to repair glomerular injury and address the significant burden of chronic kidney disease (CKD) and end-stage kidney disease (ESKD) in the U.S. and worldwide. The research will leverage Duke's expertise in human stem cell biology, organoids, organs-on-chips, and cellular reprogramming to develop innovative approaches for repairing and regenerating damaged kidney tissues. The goal is to uncover tunable molecular targets and engineer synthetic circuits for autonomous repair of injured podocytes and glomerular structures to help restore the kidney's blood filtration function. This high-risk, high-reward project aims to provide new therapeutic modalities for kidney disease, which currently lacks effective treatments to reverse or halt CKD progression to ESKD.

Generated 7/16/24, 1:57 AM